The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cell free DNA (cfDNA) assessment of esophagogastric (EG) cancer using MSK-ACCESS.
 
Samuel Louis Cytryn
Stock and Other Ownership Interests - BioNTech SE; Moderna Therapeutics; Pfizer
 
William Phu
No Relationships to Disclose
 
Ronak H. Shah
Stock and Other Ownership Interests - 10X Genomics; AstraZeneca/MedImmune; Guardant Health; Regeneron; Roche
 
Henry S. Walch
No Relationships to Disclose
 
Walid Khaled Chatila
No Relationships to Disclose
 
Efsevia Vakiani
No Relationships to Disclose
 
Angela Rose Brannon
Stock and Other Ownership Interests - Johnson & Johnson
 
Marc Ladanyi
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Paige.AI
Research Funding - Elevation Oncology (Inst); Merus NV (Inst); Rain Therapeutics
 
Amitabh Srivastava
No Relationships to Disclose
 
Laura H. Tang
Honoraria - Astellas Scientific and Medical Affairs Inc
 
Vivian E. Strong
Honoraria - Merck
 
Daniela Molena
Honoraria - Bristol-Myers Squibb/Pfizer; Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Boston Scientific; Johnson & Johnson; medtronic
 
David B. Solit
Stock and Other Ownership Interests - Elsie Biotechnologies; Fore Biotherapeutics; Function Oncology; Pyramid Biosciences; Scorpion Therapeutics; Vividion Therapeutics
Consulting or Advisory Role - BridgeBio Pharma; Elsie Biotechnologies; Fog Therapeutics; Fore Biotherapeutics; Function Oncology; PAIGE.AI (I); Pfizer; Pyramid Biosciences; Rain Therapeutics; Scorpion Therapeutics; Vividion Therapeutics
 
Michael F. Berger
Consulting or Advisory Role - AstraZeneca; Lilly; PetDx
Patents, Royalties, Other Intellectual Property - Provisional patent pending for "Systems and Methods for Detecting Cancer via cfDNA Screening"
 
Yelena Y. Janjigian
Stock and Other Ownership Interests - Inspirna
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Master Clinician Alliance; Merck; Michael J. Hennessy Associates; Peerview; Research to Practice
Consulting or Advisory Role - Abbvie; AmerisourceBergen; Arcus Biosciences; AskGene Pharma; Astellas Pharma; AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Daiichi Sankyo; Geneos; GlaxoSmithKline; Guardant Health; Imedex; Imugene; Jazz Pharmaceuticals; Lilly; Lynx Health; Merck; Merck Serono; Mersana; Michael J. Hennessy Associates; Paradigm; Peerview; Pfizer; Phanes Therapeutics; Research to Practice; Rgenix; Seagen; Silverback Therapeutics; Zymeworks
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Cycle for Survival (Inst); Department of Defense (Inst); Fred's Team (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); NCI (Inst); Rgenix (Inst); Transcenta (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb Japan; Merck
Other Relationship - Axis Medical Education; Clinical Care Options; Research to Practice